These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Evaluation of the tests used to control heparin treatment]. Chojnowski K; Judkiewicz L; Ciszewski R; Majda J Pol Tyg Lek; 1986 Feb; 41(8):239-42. PubMed ID: 3714565 [No Abstract] [Full Text] [Related]
7. [Influence of heparin electrophoresis on the functional state of the myocardium in patients with coronary atherosclerosis]. Shustval' NF Vopr Kurortol Fizioter Lech Fiz Kult; 1975; (6):530-3. PubMed ID: 1229096 [No Abstract] [Full Text] [Related]
8. [Proposals for an outline of fibrinolytic-clearing therapy in coronary diseases]. Ferliga G G Gerontol; 1967 Jul; 15(7):813-26. PubMed ID: 5606218 [No Abstract] [Full Text] [Related]
9. [Experience in the treatment of arteriosclerotic circulatory disorders using Seniosan in the general practice]. Rölke H Med Welt; 1969 Mar; 13():746-50. PubMed ID: 4185050 [No Abstract] [Full Text] [Related]
10. [Treatment of hyperlipidemia in patients with ischemic heart disease]. Haviar V; Kusá O; Riecanský I; Luknárová O Vnitr Lek; 1972 Jun; 18(6):586-91. PubMed ID: 5044447 [No Abstract] [Full Text] [Related]
11. [Treatment of coronary insufficiency. Clinical evaluation of a vasodilator agent and tranquilizer drug combination (Ro 4-6486)]. Buzzi A Med Panam; 1963 Aug; 21(4):97-9. PubMed ID: 5900011 [No Abstract] [Full Text] [Related]
12. [Radiometric determination of capillary permeability and tissue circulation in patients with coronary atherosclerosis treated with heparin]. Aleĭnikova LI; Dubovyĭ ED; Sokolov VN; Kudlaĭ VR Klin Med (Mosk); 1972 Oct; 50(10):42-5. PubMed ID: 4656248 [No Abstract] [Full Text] [Related]
13. [Effect of curantil and heparin on indices of microcirculatory and blood oxygen balance in ischemic heart disease]. Denisiuk VI Vrach Delo; 1982; (10):26-9. PubMed ID: 7179876 [No Abstract] [Full Text] [Related]
14. [The effect of heparin on the tone of the large arteries and arterial pressure in patients with coronary insufficiency]. Kibarskis Kh; Sabitova L Klin Med (Mosk); 1966 May; 44(5):57-61. PubMed ID: 5989397 [No Abstract] [Full Text] [Related]
15. Heparin in coronary artery disease: new uses for an old drug. Violaris AG; Angelini GD Br J Hosp Med; 1993 Jan 6-19; 49(1):37-9, 42-3. PubMed ID: 8347182 [TBL] [Abstract][Full Text] [Related]
16. [Experience in preventive therapy of patients with chronic coronary insufficiency under polyclinic conditions]. Paranskaia ZhA Klin Med (Mosk); 1970 Apr; 48(4):109-12. PubMed ID: 5425704 [No Abstract] [Full Text] [Related]
17. [Effect of heparin electrophoresis on myocardial function in patients with arteriosclerosis]. Shustval' NF Vrach Delo; 1976 Aug; (8):60-3. PubMed ID: 1020296 [No Abstract] [Full Text] [Related]
18. Heparin resistance during cardiopulmonary bypass. The role of heparin pretreatment. Esposito RA; Culliford AT; Colvin SB; Thomas SJ; Lackner H; Spencer FC J Thorac Cardiovasc Surg; 1983 Mar; 85(3):346-53. PubMed ID: 6827843 [No Abstract] [Full Text] [Related]
19. [Experience with the management of ischemic heart disease using antisclerotic doses of heparin]. Haviar V; Marcisová M; Kusá O Vnitr Lek; 1970 May; 16(5):438-41. PubMed ID: 5425223 [No Abstract] [Full Text] [Related]
20. [Experience with the use of high intravenous doses of a coronary-active drug in the treatment of acute and chronic coronary insufficiency]. Cinelli P; Grazzini M Minerva Cardioangiol; 1969 May; 17(5):317-23. PubMed ID: 5814987 [No Abstract] [Full Text] [Related] [Next] [New Search]